Product Information

MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0773 per EA under NDC 00904681706. Its NADAC has been published 264 times since Oct 27, 2021.

FDA first approved this application on Sep 12, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Midodrine Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MIDODRINE HCL 2.5 MG TABLET

Midodrine Hydrochloride
$0.0773per EA
Low Outlier

Strength

2.5 mg/1

NDC

00904681706

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MIDODRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077746

FDA Approved

9/12/2006

TE Code

AB

On Market Since

9/12/2006

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 264 times since Oct 27, 2021, and over the history we have for it it has declined 67.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0773 per EA
All-time high$0.2450 (Dec 15, 2021)
All-time low$0.0668 (Nov 20, 2024)
52-week high$0.0773
52-week low$0.0703
Median price$0.1086
Average price$0.1285
Largest weekly change+59.2% (Nov 22, 2023)
Weeks tracked264
Tracking sinceOct 27, 2021

Price History

1W

0.0%

1M

+4.9%

3M

+6.1%

6M

+4.5%

1Y

+8.6%

3Y

-30.9%

5Y

-68.5%

All

-67.0%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0773 per EA (NDC 00904681706), effective Nov 11, 2026.

How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 67.0%. It has been tracked across 264 weekly CMS publications since Oct 27, 2021.

What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?

Since Oct 27, 2021, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.2450 (Dec 15, 2021), with a median of $0.1086 per EA.

Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIDODRINE HCL 2.5 MG TABLET?

MIDODRINE HCL 2.5 MG TABLET (NDC 00904681706) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.